서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Publisher

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 16 of 16

Issue DateTitle / Author(s) / CitationFileAltmetrics
2011
TB diagnostics: Current pipeline, new developments and unmet needs

Pai, Madhukar; Schumacher, Samuel G.; Sohn, Hojoon; Denkinger, Claudia M.

Current and Emerging Diagnostics, Therapeutics and Vaccines for Tuberculosis, pp.23-41

DOI
2011-01
Effect of platelet-rich plasma on dental stem cells derived from human impacted third molars

Lee, Ui-Lyong; Jeon, Soung Hoo; Park, Joo-Young; Choung, Pill-Hoon

Regenerative Medicine, Vol.6 No.1, pp.67-79

DOI
2011-10
Surface-enhanced Raman scattering-active nanostructures and strategies for bioassays
DOI
2012-02
Development and in vivo imaging of a PET/MRI nanoprobe with enhanced NIR fluorescence by dye encapsulation
DOI
2013-07
Comparative analysis of mesenchymal stem cell surface marker expression for human dental mesenchymal stem cells
DOI
2015-05
Adipose-derived human mesenchymal stem cells induce long-term neurogenic and anti-inflammatory effects and improve cognitive but not motor performance in a rat model of Parkinson's disease
DOI
2019-02
Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design
DOI
2019-03
KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer
DOI
2021-02
First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
DOI
2021-03
KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma
DOI
2021-08
Plain language summary of the CROWN study comparing lorlatinib with crizotinib for people with untreated non-small cell lung cancer
DOI
2023-05
Plain language summary of the updated results from the CROWN study comparing lorlatinib with crizotinib in people with advanced non-small-cell lung cancer
DOI
2024-01
The effects of adding palbociclib to endocrine therapy to treat advanced breast cancer: a plain language summary of a study using the PALOMA-2 and PALOMA-3 trial results
DOI
2024-01
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary
DOI
2024-02
Pralsetinib in patients with RET fusion-positive non-small cell lung cancer: A plain language summary of the ARROW study
DOI
2024-03
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2-breast cancer
DOI
1